Immediate evaluation of global longitudinal strain at initiation of trastuzumab treatment in breast cancer patients.
Ann BankeMorten SchouMarianne EwertzJordi DahlPeter Hartmund FrederiksenLars VidebaekSøren ColdJacob E MøllerPublished in: Echocardiography (Mount Kisco, N.Y.) (2021)
In this study deteriorations in key echocardiographic parameters within normal limits were detected during the first 2 weeks of trastuzumab treatment, and an early ≥10% deterioration in GLS was associated with a lower LVEF at 9 months.